К содержанию
РецензированоEN2022

Renewed approach to managment of rheumatoid arthritis in early stages

Nabiyeva D.A. · Tashpulatova M.M.

Научные статьи · 2022

Аннотация

The study included 90 patients with significant RA disease with duration up to 3 years. By random assignment, patients were randomized into three groups: 1st group monotherapy with methotrexate (MTX) 10-20 mg / week (MTX; n = 40); 2nd group – MTX combined with small doses of glucocorticosteroids (GC) prednisolone in a dose of 10 mg per day orally (MTX + GC; n = 30); 3rd group - monotherapy with leflunomide (LF) 20 mg / day (LF; n = 20). Patients were allowed to continue taking nonsteroidal anti-inflammatory drugs (NSAIDs) in the previous doses, as well as external using of anti-inflammatory drugs, exercise therapy, physiotherapy and occupational therapy if demanded,. If necessary, conducted intra-articular GC, but no more than 1 per in 1 month using 1 ml diprospan per administration. All patients before treatment and during follow-held standart clinical, laboratory and instrumental examination. Total activity of disease assessed by DAS28 index which recommended by the EULAR with the release of the 4 major powers

Доказательный фрагмент

«The study included 90 patients with significant RA disease with duration up to 3 years.»

Образец извлечения

Демо-превью

The study included 90 patients with significant RA disease with duration up to 3 years. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

DOI не указан
Цитирований
0
Тип
Журнал
Страна
Узбекистан
Спросить CiteX об этой работе

Смежные источники